Want to join the conversation?
$PBCT 2Q15 Q&A Update – David, CFO: On rising other non-interest expense line QoverQ, advertising was up in 2Q15 in conjunction with campaign that John talked about at the beginning of his comments and also in 1Q15, we had a little better experience on REO sales, but advertising is just timing issue. So, no real uptick in that line item is expected
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?